AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAPT Therapeutics, Inc. Director's Dealing 2021

Sep 23, 2021

32942_dirs_2021-09-22_db1d80f3-c26c-4e40-a8f1-f25390b81512.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-09-20

Reporting Person: HO WILLIAM (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-20	Common Stock	S	2000	$40	Disposed	63106	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F2: The total amount of beneficially owned shares is amended to correct misinformation provided by the broker. 2,000 shares reported as sold on 9/17/2021 were not sold and were subsequently sold on 9/20/2021.